Skip to main content
Quest Diagnostics Home

The Link Between Gut Health and Cardiovascular Disease

Date: Friday, Jun 14, 2019

Description: Dr. Kahn helps participants understand the link between the gut microbiome and cardiovascular risk, know the role of trimethylene N-oxide (TMAO) as an indicator of cardiovascular (CVD) risk and identify ways to uncover and manage CVD risk with advanced testing, including TMAO. At the end of the presentation, participants will be able to: • Understand the link between the gut microbiome and cardiovascular risk • Know the role of trimethylene N-oxide (TMAO) as an indicator of cardiovascular (CVD) risk • Identify ways to uncover and manage CVD risk with advanced testing, including TMAO ASCLS P.A.C.E.® credits are available to laboratory professionals through December 4, 2019.

Author:
Kahn, Joel, MD, FACC
Founder
Kahn Center for Cardiac Longevity
Clinical Professor of Medicine
Wayne State University School of Medicine
Detroit, Michigan 

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2023 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.